Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 173

1.

Comparison of FIB-4 and APRI in HIV-HCV coinfected patients with normal and elevated ALT.

Shah AG, Smith PG, Sterling RK.

Dig Dis Sci. 2011 Oct;56(10):3038-44. doi: 10.1007/s10620-011-1710-2. Epub 2011 Apr 28.

PMID:
21526398
[PubMed - indexed for MEDLINE]
2.

Comparison of FIB-4 and APRI in Chinese HBV-infected patients with persistently normal ALT and mildly elevated ALT.

Wang H, Xue L, Yan R, Zhou Y, Wang MS, Cheng MJ, Huang HJ.

J Viral Hepat. 2013 Apr;20(4):e3-10. doi: 10.1111/jvh.12010. Epub 2012 Nov 19.

PMID:
23490387
[PubMed - indexed for MEDLINE]
3.

Validation and comparison of simple noninvasive models for the prediction of liver fibrosis in chronic hepatitis C.

Amorim TG, Staub GJ, Lazzarotto C, Silva AP, Manes J, Ferronato Mda G, Shiozawa MB, Narciso-Schiavon JL, Dantas-Correa EB, Schiavon Lde L.

Ann Hepatol. 2012 Nov-Dec;11(6):855-61.

PMID:
23109448
[PubMed - indexed for MEDLINE]
4.

Role of AST to platelet ratio index in the detection of liver fibrosis in patients with recurrent hepatitis C after liver transplantation.

Toniutto P, Fabris C, Bitetto D, Falleti E, Avellini C, Rossi E, Smirne C, Minisini R, Pirisi M.

J Gastroenterol Hepatol. 2007 Nov;22(11):1904-8.

PMID:
17914968
[PubMed - indexed for MEDLINE]
5.

[Retrospective study of FibroScan, APRI, FIB-4 and FORNS indexes compared with liver biopsy in the evaluation of liver fibrosis in patients with chronic hepatitis C monoinfection and HIV coinfection].

González Guilabert MI, Hinojosa Mena-Bernal C, del Pozo González J, del Pozo Pérez MA.

Gastroenterol Hepatol. 2010 Jun-Jul;33(6):425-32. doi: 10.1016/j.gastrohep.2010.02.005. Epub 2010 May 14. Spanish.

PMID:
20471720
[PubMed - indexed for MEDLINE]
6.

Validation of a simple model for predicting liver fibrosis in HIV/hepatitis C virus-coinfected patients.

Al-Mohri H, Cooper C, Murphy T, Klein MB.

HIV Med. 2005 Nov;6(6):375-8.

PMID:
16268817
[PubMed - indexed for MEDLINE]
7.

Correlation of transient elastography with APRI and FIB-4 in a cohort of patients with congenital bleeding disorders and HCV or HIV/HCV coinfection.

Vidovic N, Lochowsky RS, Goldmann G, Rockstroh J, Wasmuth JC, Spengler U, Sauerbruch T, Lammert F, Oldenburg J, Grünhage F.

Haemophilia. 2010 Sep 1;16(5):778-85. doi: 10.1111/j.1365-2516.2010.02204.x. Epub 2010 Mar 15.

PMID:
20331759
[PubMed - indexed for MEDLINE]
8.

Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection.

Sterling RK, Lissen E, Clumeck N, Sola R, Correa MC, Montaner J, S Sulkowski M, Torriani FJ, Dieterich DT, Thomas DL, Messinger D, Nelson M; APRICOT Clinical Investigators.

Hepatology. 2006 Jun;43(6):1317-25.

PMID:
16729309
[PubMed - indexed for MEDLINE]
9.

Comparison and validation of simple noninvasive tests for prediction of fibrosis in chronic hepatitis C.

Lackner C, Struber G, Liegl B, Leibl S, Ofner P, Bankuti C, Bauer B, Stauber RE.

Hepatology. 2005 Jun;41(6):1376-82.

PMID:
15915455
[PubMed - indexed for MEDLINE]
10.

Noninvasive serum fibrosis markers for screening and staging chronic hepatitis C virus patients in a large US cohort.

Holmberg SD, Lu M, Rupp LB, Lamerato LE, Moorman AC, Vijayadeva V, Boscarino JA, Henkle EM, Gordon SC; Chronic Hepatitis Cohort Study (CHeCS) Investigators.

Clin Infect Dis. 2013 Jul;57(2):240-6. doi: 10.1093/cid/cit245. Epub 2013 Apr 16.

PMID:
23592832
[PubMed - indexed for MEDLINE]
Free Article
11.

Optimized cutoffs improve performance of the aspartate aminotransferase to platelet ratio index for predicting significant liver fibrosis in human immunodeficiency virus/hepatitis C virus co-infection.

Carvalho-Filho RJ, Schiavon LL, Narciso-Schiavon JL, Sampaio JP, Lanzoni VP, Ferraz ML, Silva AE.

Liver Int. 2008 Apr;28(4):486-93. doi: 10.1111/j.1478-3231.2008.01675.x.

PMID:
18339075
[PubMed - indexed for MEDLINE]
12.

[Utility of 2 biochemical models predictive of liver fibrosis grade in prison inmates with hepatitis C].

Portilla J, López-Burgos A, Saiz-De-La-Hoya-Zamácola P, Sánchez-Payá J, Bedía-Collantes M, Faraco-Atienzar I, Lissen E.

Gastroenterol Hepatol. 2009 Jun-Jul;32(6):387-94. doi: 10.1016/j.gastrohep.2009.01.176. Epub 2009 May 27. Spanish.

PMID:
19477553
[PubMed - indexed for MEDLINE]
13.

HIV infection does not affect the performance of noninvasive markers of fibrosis for the diagnosis of hepatitis C virus-related liver disease.

Nunes D, Fleming C, Offner G, O'Brien M, Tumilty S, Fix O, Heeren T, Koziel M, Graham C, Craven DE, Stuver S, Horsburgh CR Jr.

J Acquir Immune Defic Syndr. 2005 Dec 15;40(5):538-44.

PMID:
16284529
[PubMed - indexed for MEDLINE]
14.

Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease.

McPherson S, Stewart SF, Henderson E, Burt AD, Day CP.

Gut. 2010 Sep;59(9):1265-9. doi: 10.1136/gut.2010.216077.

PMID:
20801772
[PubMed - indexed for MEDLINE]
15.

Non-invasive tests in prediction of liver fibrosis in chronic hepatitis B and comparison with post-antiviral treatment results.

Başar O, Yimaz B, Ekiz F, Giniş Z, Altinbaş A, Aktaş B, Tuna Y, Çoban S, Delibaş N, Yüksel O.

Clin Res Hepatol Gastroenterol. 2013 Apr;37(2):152-8. doi: 10.1016/j.clinre.2012.07.003. Epub 2013 Feb 4.

PMID:
23391746
[PubMed - indexed for MEDLINE]
16.

Change in fibrosis score as a predictor of mortality among HIV-infected patients with viral hepatitis.

Jain MK, Seremba E, Bhore R, Dao D, Joshi R, Attar N, Yuan HJ, Lee WM.

AIDS Patient Care STDS. 2012 Feb;26(2):73-80. doi: 10.1089/apc.2011.0191. Epub 2012 Jan 12.

PMID:
22239101
[PubMed - indexed for MEDLINE]
17.

Evaluating liver fibrosis progression and the impact of antiretroviral therapy in HIV and hepatitis C coinfection using a noninvasive marker.

Al-Mohri H, Murphy T, Lu Y, Lalonde RG, Klein MB.

J Acquir Immune Defic Syndr. 2007 Apr 1;44(4):463-9.

PMID:
17211282
[PubMed - indexed for MEDLINE]
18.

Validation of three non-invasive markers in assessing the severity of liver fibrosis in chronic hepatitis C.

Shaikh S, Memon MS, Ghani H, Baloch GH, Jaffery M, Shaikh K.

J Coll Physicians Surg Pak. 2009 Aug;19(8):478-82. doi: 08.2009/JCPSP.478482.

PMID:
19651008
[PubMed - indexed for MEDLINE]
19.

Evaluation of liver fibrosis: concordance analysis between noninvasive scores (APRI and FIB-4) evolution and predictors in a cohort of HIV-infected patients without hepatitis C and B infection.

Mendeni M, Focà E, Gotti D, Ladisa N, Angarano G, Albini L, Castelnuovo F, Carosi G, Quiros-Roldan E, Torti C.

Clin Infect Dis. 2011 May;52(9):1164-73. doi: 10.1093/cid/cir071.

PMID:
21467023
[PubMed - indexed for MEDLINE]
Free Article
20.

FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. comparison with liver biopsy and fibrotest.

Vallet-Pichard A, Mallet V, Nalpas B, Verkarre V, Nalpas A, Dhalluin-Venier V, Fontaine H, Pol S.

Hepatology. 2007 Jul;46(1):32-6.

PMID:
17567829
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk